MedTrace Logo

Diabetes Smoking Cessation Incentives Study

NCT04682067 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2022-05-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the feasibility of contingency management on improving smoking cessation among individuals with type 2 diabetes.

Conditions

  • Smoking Cessation
  • Diabetes Type 2

Interventions

BEHAVIORAL

Contingency Management

Escalating financial incentives contingent upon biochemical evidence of abstinence

BEHAVIORAL

Usual Care smoking cessation

Usual care smoking cessation support

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Sydney Martinez, PhD · University of Oklahoma

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-08
Primary Completion
2022-04-07
Completion
2022-04-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04682067 on ClinicalTrials.gov